Wednesday, June 10, 2026

pharma · Dravet syndrome · Primary Hyperoxaluria (PH) of all subtypes (PH1, PH2 and PH3)

Biocodex

Biocodex patent portfolio — 25 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

Gentilly, FR HQ
1953 Founded
1,648 Employees
EMA registrant Type
Company details
Status
Public
HQ
Gentilly, FR
Founded
1953
Employees
1,648
Programs
5
Drugs
15
Patents
25
Intelligence · Patents

Biocodex patents

25 pharmaceutical patents indexed for Biocodex. 0 expire within 24 months.

Biocodex has 25 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.

Patent portfolio

  1. WO 2026013310

    COMPOSITION PHARMACEUTIQUE LIQUIDE À BASE DE STIRIPENTOL

    Expires Wed Jan 10 2046 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  2. WO 2024194388

    PREPARATION DE LEVURE SACCHAROMYCES BOULARDII INACTIVEE

    Expires Wed Sep 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  3. WO 2023046844

    COMPOSITIONS PHARMACEUTIQUES UTILES POUR LA PRÉVENTION OU LE TRAITEMENT D'INFECTIONS VIRALES

    Expires Wed Mar 25 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  4. FR 3121841

    Traitement des hyperammoniémies

    Expires Thu Oct 16 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  5. EP 3964220

    PHARMAZEUTISCHE ZUSAMMENSETZUNG ZUR BEHANDLUNG VON OSTEOPOROSE

    Expires Tue Mar 04 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  6. EP 3485879

    ORALE PHARMAZEUTISCHE FORMULIERUNG ENTHALTEND BAKTERIEN

    Expires Tue May 17 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  7. CA 3072544

    SACCHAROMYCES BOULARDII POUR LE TRAITEMENT DES TROUBLES DE L'HUMEUR

    Expires Wed Feb 09 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  8. CA 3065417

    TRAITEMENT DE MALADIES ASSOCIEES A UNE DYSREGULATION DE LA VOIE MTOR

    Expires Wed Dec 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  9. WO 2017194692

    DERIVES DE LA BENZOXAZINE OU DE LA QUINAZOLINE POUR LEUR UTILISATION DANS LE TRAITEMENT DE LA MALADIE D'ALZHEIMER

    Expires Wed Nov 11 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  10. CA 3022447

    COMPOSITION UTILE POUR LA PREPARATION D'UN OVULE

    Expires Wed Oct 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  11. CA 2951771

    COMPOSITIONS ET METHODES PERMETTANT DE PREVENIR LES INFECTIONS

    Expires Wed Dec 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  12. FR 3016881

    TRAITEMENT DES DEGENERESCENCES ET DES LESIONS PHOTO-INDUITES DE LA RETINE

    Expires Thu Jul 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  13. EP 2886116

    Benzodioxol-Derivate zur Verwendung in der Behandlung von Aufmerksamkeitsdefizitstörung und/oder Hyperaktivität

    Expires Tue Jun 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  14. EP 2875810

    Pharmakologische Behandlung von Zwangsstörungen unter Verwendung von Stiripentol oder einer ähnlichen Verbindung

    Expires Tue May 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  15. EP 2870969

    Pharmazeutische Zusammensetzung zur Reduzierung der adipösen Masse

    Expires Tue May 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  16. FR 3005577

    TRAITEMENT DE L'INCONFORT BUCCAL

    Expires Thu Nov 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  17. FR 2972192

    COMPOSITION PHARMACEUTIQUE DESTINEE A LA PREVENTION OU AU TRAITEMENT DES CANCERS

    Expires Thu Sep 02 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  18. FR 2955495

    MEDICAMENT POUR LA REDUCTION DE LA CHOLESTEROLEMIE

    Expires Thu Jul 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  19. CA 2724937

    MEDICAMENT POUR LE TRAITEMENT DES ULCERES GASTRO-INTESTINAUX

    Expires Tue Jun 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  20. CA 2724303

    COMBINAISON SYNERGIQUE DE COMPOSES ANALGESIQUES

    Expires Thu May 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  21. EP 2229943

    Verbindungen zur Behandlung der peripheren Neuropathie

    Expires Tue Sep 17 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  22. EP 2201950

    Verbindungen und Verfahren zur Behandlung von autistischen Spektrumsstörungen

    Expires Tue Jun 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  23. FR 2937553

    COMBINAISON SYNERGIQUE DE COMPOSES ANALGESIQUES

    Expires Thu Apr 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  24. EP 2179734

    Benzoxazin- und Dihydrochinazolinderivate zur Verwendung in der Behandlung von Alkoholentzugssyndrom

    Expires Tue Apr 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  25. WO 2010030203

    ANTICORPS MONOCLONAL DIRIGÉ CONTRE LA TRANSTHYRÉTINE HUMAINE AMYLOÏDOGÈNE ET DES FORMES MODIFIÉES DE CELLE-CI ET SON UTILISATION DANS LA DÉTECTION ET LE TRAITEMENT DE LA FAP ET DE PATHOLOGIES PRÉSENTANT UNE TTR MODIFIÉE

    Expires Wed Mar 13 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Biocodex have?

25 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Biocodex patents expire?

0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.